亚洲色怡人综合网站,国产性夜夜春夜夜爽,久久97AV综合,国产色视频一区二区三区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharmaceutical companies to show anti-COVID-19 products at third CIIE

By XING YI in Shanghai | chinadaily.com.cn | Updated: 2020-07-26 22:19
Share
Share - WeChat

A "matchmaking" meeting for the China International Import Expo was held in Shanghai on Sunday for companies showcasing products to be put in the expo's new section for public health and epidemic prevention.

Small bottles labelled with "Vaccine" stickers seen near a medical syringe in front of displayed "Coronavirus COVID-19" words, April 10, 2020. [Photo/Agencies]

The annual expo will be held as scheduled from Nov 5 to 10, and the "matchmaking" is among the events to mark the 100-day countdown to the expo.

Liu Jiang, a sales head with PerkinElmer, a diagnostic solutions provider, said the company will introduce a mobile lab equipped with modules from sample preparation to testing, which can be mounted on a van or a truck.

"It provides an easily deployable and versatile solution to respond to an epidemic, like small clusters of COVID-19 outbreaks," Liu said.

Qiu Jianping, general manager of Abbott Rapid Diagnostics China, said the products the company will display at the expo include a fast blood testing system that was donated to Huoshenshan and Leishenshang makeshift hospitals in Wuhan when the city was stricken by COVID-19 in February.

The exhibitors also founded a special committee on public health and epidemic prevention. Major pharmaceutical companies, such as Johnson & Johnson, Roche and Sanofi, were among its founding members.

Drug maker MSD served as the first rotating president of the committee. Its China branch president, Joseph Romanelli, said the companies are developing two vaccines against COVID-19, which will likely go into the clinical stage soon.

"There are probably more than 100 COVID-19 vaccine candidates being reviewed … I think what we will see at the CIIE is an opportunity to talk about the diversity of vaccines," he said.

Wu Kun, the China COO of Pfizer Biopharma Group, said the company will have a 150-square-meter exhibition area in the new section to showcase its vaccine development and its efforts in fighting the COVID-19 pandemic.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE